RW
Robert Wasserman Benchmark Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$3.25B
| $166.75 | $175 |
5%
upside
| Buy |
2 Sep ‘25
6 days ago |
|
2
Intensity Therapeutics
INTS
$13.3M
| $0.2821 | $1.50 |
432%
upside
| Speculative Buy |
20 Aug ‘25
19 days ago |
|
3
Bio-Techne
TECH
$8.46B
| $54.41 | $75 |
38%
upside
| Buy |
5 Jun ‘25
3 months ago |
|
4
Kamada
KMDA
$411M
| $7.14 | $15 |
110%
upside
| Buy |
15 May ‘25
3 months ago |
|
5
OmniAb
OABI
$246M
| $1.71 | $6 |
251%
upside
| Buy |
12 May ‘25
3 months ago |
|
6
Integer Holdings
ITGR
$3.75B
| $106.94 | $140 |
31%
upside
| Buy |
25 Apr ‘25
4 months ago |
|
7
Xoma
XOMA
$426M
| $35.24 | $35 |
1%
downside
| Buy |
17 Apr ‘25
4 months ago |
|
|
HYFT
8
MindWalk Holdings Corp. Common Stock
HYFT
$89.5M
| $1.94 | $3 |
55%
upside
| Speculative Buy |
1 Apr ‘25
5 months ago |
|
9
Halozyme
HALO
$8.76B
| $74.93 | $75 |
0%
upside
| Buy |
20 Feb ‘25
6 months ago |
|
10
BioLife Solutions
BLFS
$1.27B
| $26.46 | $30 |
13%
upside
| Buy |
19 Dec ‘24
8 months ago |
|
11
Anebulo Pharmaceuticals
ANEB
$97.8M
| $2.38 | $8 |
236%
upside
| Speculative Buy |
19 Nov ‘24
9 months ago |
|
12
Nephros
NEPH
$40.6M
| $3.83 | $5 |
31%
upside
| Speculative Buy |
12 Nov ‘24
10 months ago |
|
13
Emergent Biosolutions
EBS
$404M
| $7.58 | $12 |
58%
upside
| Buy |
7 Nov ‘24
10 months ago |
|
14
Protolabs
PRLB
$1.19B
| $49.93 | $45 |
10%
downside
| Buy |
29 May ‘24
1 year ago |
|
15
Processa Pharmaceuticals
PCSA
$8.65M
| $0.1718 | $4 |
2,228%
upside
| Speculative Buy |
6 Mar ‘24
1 year ago |
|
16
Fortress Biotech
FBIO
$110M
| $3.71 | $75 |
1,922%
upside
| Speculative Buy |
6 Apr ‘23
2 years ago |
|
17
Thermo Fisher Scientific
TMO
$186B
| $492.60 | $580 |
18%
upside
| Buy |
16 Jul ‘21
4 years ago |
|